Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01076101 · ClinicalTrials.gov registry record

Autoimmunity in Sisters of Lupus Patients

A clinical trial, sponsored by Northwell Health.

Completed
Registry status
817
Enrollment target

NCT01076101: Completed study, sponsored by Northwell Health.

NCT01076101 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 817 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01076101 has completed, sponsored by Northwell Health.

COMPLETED
Registry status
817 participants
Enrollment target

Study Summary

This study enrolled over 400 unaffected sisters of young women diagnosed with SLE. These unaffected sisters are being followed with an annual health questionnaire (CSQ) and blood sample.

Trial Details

FieldValue
Enrollment Target 817 participants
Start Date 2009-02
Est. Completion 2016-12-31
Northwell Health

370 total trials

What the finished NCT01076101 record still lists

NCT01076101 is an observational study that tracks outcomes without assigning an intervention. The registered 817 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01076101 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01076101 about?

NCT01076101 is a clinical study titled "Autoimmunity in Sisters of Lupus Patients". This study enrolled over 400 unaffected sisters of young women diagnosed with SLE. These unaffected sisters are being followed with an annual health questionnaire (CSQ) and blood sample.

What is the current status of trial NCT01076101?

This trial is currently completed. The enrollment target is 817 participants. The study started on 2009-02. Estimated completion is 2016-12-31.

Who is sponsoring clinical trial NCT01076101?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04846959 · 818 participants

    Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications

  • NCT07218029 · 815 participants · Phase 3

    A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

  • NCT04028687 · 820 participants

    MDR - PMCF Study for Taperloc Complete Stems

  • NCT04613440 · 820 participants · NA

    FaCT Trial (Facilitated Cascade Testing Trial)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01076101, the US trial registry maintained by the National Library of Medicine. NCT01076101 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.